Literature DB >> 28935055

Screening and Management of Substance Use in Pregnancy: A Review.

Jocelynn L Cook1, Courtney R Green2, Sandra de la Ronde3, Colleen A Dell4, Lisa Graves5, Lisa Morgan6, Alice Ordean7, James Ruiter8, Megan Steeves9, Suzanne Wong10.   

Abstract

Substance use during pregnancy has important implications for health care providers, policy makers, and can negatively impact a woman's health and the health of her children. Understanding trends, patterns of use and outcomes are critical to prevention campaigns, building awareness, and providing effective care. This review will discuss the current therapeutic approaches and recommendations for screening and patient management for substance use in pregnancy and during the postpartum period, and it is geared towards any care providers who care for patients or those who may care for patients who may be at risk for substance use during pregnancy.
Copyright © 2017 Society of Obstetricians and Gynaecologists of Canada. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Substance use; cannabis; hallucinogens; opioids; pregnancy; stimulants

Mesh:

Year:  2017        PMID: 28935055     DOI: 10.1016/j.jogc.2017.07.017

Source DB:  PubMed          Journal:  J Obstet Gynaecol Can        ISSN: 1701-2163


  9 in total

1.  Association Between Self-reported Prenatal Cannabis Use and Maternal, Perinatal, and Neonatal Outcomes.

Authors:  Daniel J Corsi; Laura Walsh; Deborah Weiss; Helen Hsu; Darine El-Chaar; Steven Hawken; Deshayne B Fell; Mark Walker
Journal:  JAMA       Date:  2019-07-09       Impact factor: 56.272

2.  Rising syphilis rates in Canada, 2011-2020.

Authors:  Josephine Aho; Cassandra Lybeck; Ashorkor Tetteh; Carmen Issa; Fiona Kouyoumdjian; Jason Wong; Alexandrea Anderson; Nashira Popovic
Journal:  Can Commun Dis Rep       Date:  2022-02-24

3.  Maternal Substance Abuse and the Later Risk of Fractures in Offspring: L'abus maternel de substances et le risque ultérieur de fractures chez les enfants.

Authors:  Nathalie Auger; Nancy Low; Aimina Ayoub; Ga Eun Lee; Thuy Mai Luu
Journal:  Can J Psychiatry       Date:  2020-11-03       Impact factor: 4.356

Review 4.  Scoping Review of the Associations Between Perinatal Substance Use and Perinatal Depression and Anxiety.

Authors:  Ryoko Pentecost; Gwen Latendresse; Marcela Smid
Journal:  J Obstet Gynecol Neonatal Nurs       Date:  2021-03-25

5.  Overall Maternal Morbidity during Pregnancy Identified with the WHO-WOICE Instrument.

Authors:  Stephanie Pabon; Mary A Parpinelli; Martha B Narvaez; Charles M'poca Charles; Jose P Guida; Maria F Escobar; Jose G Cecatti; Maria L Costa
Journal:  Biomed Res Int       Date:  2020-07-17       Impact factor: 3.411

Review 6.  Economic Evaluation of Interventions for Treatment of Neonatal Opioid Withdrawal Syndrome: A Review.

Authors:  Evelyn Lee; Deborah Schofield; Syeda Ishra Azim; Ju Lee Oei
Journal:  Children (Basel)       Date:  2021-06-23

7.  Trends and correlates of cannabis use in pregnancy: a population-based study in Ontario, Canada from 2012 to 2017.

Authors:  Daniel J Corsi; Helen Hsu; Deborah Weiss; Deshayne B Fell; Mark Walker
Journal:  Can J Public Health       Date:  2018-11-01

8.  Brain-Derived Extracellular Vesicle microRNA Signatures Associated with In Utero and Postnatal Oxycodone Exposure.

Authors:  Farah Shahjin; Rahul S Guda; Victoria L Schaal; Katherine Odegaard; Alexander Clark; Austin Gowen; Peng Xiao; Steven J Lisco; Gurudutt Pendyala; Sowmya V Yelamanchili
Journal:  Cells       Date:  2019-12-19       Impact factor: 6.600

9.  Cannabis use disorder and the future risk of cardiovascular disease in parous women: a longitudinal cohort study.

Authors:  Nathalie Auger; Gilles Paradis; Nancy Low; Aimina Ayoub; Siyi He; Brian J Potter
Journal:  BMC Med       Date:  2020-11-19       Impact factor: 8.775

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.